These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 9813666

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
    Pearson L, Garcia J, Wu F, Modesti N, Nelson J, Gaynor R.
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
    [Abstract] [Full Text] [Related]

  • 4. Construction and characterization of a potent HIV-2 Tat transdominant mutant protein.
    Echetebu CO, Rhim H, Herrmann CH, Rice AP.
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):655-64. PubMed ID: 8207644
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
    Lisziewicz J, Sun D, Smythe J, Lusso P, Lori F, Louie A, Markham P, Rossi J, Reitz M, Gallo RC.
    Proc Natl Acad Sci U S A; 1993 Sep 01; 90(17):8000-4. PubMed ID: 8367455
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.
    Taylor JP, Pomerantz RJ, Raj GV, Kashanchi F, Brady JN, Amini S, Khalili K.
    J Virol; 1994 Jun 01; 68(6):3971-81. PubMed ID: 8189531
    [Abstract] [Full Text] [Related]

  • 10. Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.
    Jeyaseelan R, Kurabayashi M, Kedes L.
    AIDS Res Hum Retroviruses; 1996 May 01; 12(7):569-76. PubMed ID: 8743082
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys.
    Brother MB, Chang HK, Lisziewicz J, Su D, Murty LC, Ensoli B.
    Virology; 1996 Aug 01; 222(1):252-6. PubMed ID: 8806505
    [Abstract] [Full Text] [Related]

  • 15. Recruitment of the TATA-binding protein to the HIV-1 promoter is a limiting step for Tat transactivation.
    Majello B, Napolitano G, Lania L.
    AIDS; 1998 Oct 22; 12(15):1957-64. PubMed ID: 9814863
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of HIV-1 replication by anti-trans-activation responsive polyamide nucleotide analog.
    Kaushik N, Basu A, Pandey VN.
    Antiviral Res; 2002 Oct 22; 56(1):13-27. PubMed ID: 12323396
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
    Okamoto H, Cujec TP, Okamoto M, Peterlin BM, Baba M, Okamoto T.
    Virology; 2000 Jul 05; 272(2):402-8. PubMed ID: 10873784
    [Abstract] [Full Text] [Related]

  • 18. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
    Fujinaga K, Irwin D, Geyer M, Peterlin BM.
    J Virol; 2002 Nov 05; 76(21):10873-81. PubMed ID: 12368330
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
    Kashanchi F, Sadaie MR, Brady JN.
    Virology; 1997 Jan 20; 227(2):431-8. PubMed ID: 9018142
    [Abstract] [Full Text] [Related]

  • 20. Wild-type and transactivation-defective mutants of human immunodeficiency virus type 1 Tat protein bind human TATA-binding protein in vitro.
    Wang Z, Morris GF, Rice AP, Xiong W, Morris CB.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun 01; 12(2):128-38. PubMed ID: 8680883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.